Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.

Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.

Item
http://www.wikidata.org/entity/Q37109711
Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathwayDetection of IKKε by immunohistochemistry in primary breast cancer: association with EGFR expression and absence of lymph node metastasis.Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer.A review of the importance of immune responses in luminal B breast cancer.Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkersIntracellular galectin-7 expression in cancer cells results from an autocrine transcriptional mechanism and endocytosis of extracellular galectin-7.Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer.Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9.The emerging role of galectins in high-fatality cancers.Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis.
P2860

Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.

Item
http://www.wikidata.org/entity/Q37109711
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Galectin signatures contribute ...... ation and therapeutic targets.
@en
Galectin signatures contribute ...... ation and therapeutic targets.
@nl
type
label
Galectin signatures contribute ...... ation and therapeutic targets.
@en
Galectin signatures contribute ...... ation and therapeutic targets.
@nl
prefLabel
Galectin signatures contribute ...... ation and therapeutic targets.
@en
Galectin signatures contribute ...... ation and therapeutic targets.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Galectin signatures contribute ...... ation and therapeutic targets.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932